Ovarian Carcinoma Cell Supernatants Inhibit Proliferation and IL-2R Expression of CD8~+ T Cell

Li Xiao

2003-01-01

Abstract:Objective To study the effect of supernatants derived from three ovarian carcinoma cell lines on proliferation and function of CD8 + T cell and to investigate the mechanism by which ovarian carcinoma escapes from immune recognition. Methods CD8 + T cells were cultured in complete RPMI 1640 with or without supernatants of three ovarian carcinoma cell lines (OVCAR 3, CAOV 3 and SKOV 3). Proliferation of CD8 + T cell was determined by MTT. Flow cytometry was used to detect the expressions of IL-2Rα, β and γ c on CD8 + T cell surface. ELISA was used to detect the concentration of sIL-2R in the CD8 + T cell supernatants. Results (1) All culture supernatants (OVCAR 3, CAOV 3 and SKOV 3) derived from three ovarian carcinoma cell lines inhibited the proliferation of CD8 + T cell. When the concentration of supernatants was 25%, P value was 0.004,0.006,0.013 respectively; when the concentration of supernatants was 50%, P value was 0.002, 0.003, 0.005 respectively; when the concentration of supernatants was 75%, P value was 0.001. The degree of inhibition was dose dependent. (2) The expressions of IL-2R β and γ c on CD8 + T cell surface were down-regulated significantly by all ovarian carcinoma cell culture supernatants, P value was 0.002, 0.013, 0.011 and 0.015, 0.039, 0.040 respectively. The expression of IL-2Rα was also down-regulated, but not significantly, P value was 0.235, 0.224 and 0.498 respectively. (3) The concentration of sIL-2R significantly elevated in the supernatant of CD8 + T cell which was cultured with ovarian carcinoma cell supernatants, P value was 0.008, 0.010 and 0.005 respectively. Conclusion Soluble factors derived from ovarian carcinoma inhibited the proliferation and function of CD8 + T cell, which might be one of the mechanisms by which the local immunity in the peritoneal cavity of ovarian carcinoma was suppressed.